Patents by Inventor Vic Knauf

Vic Knauf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070067870
    Abstract: The present invention relates to compositions and methods for preparing gamma-linoleic acid (GLA) in safflower plants, particularly from seeds of safflower. Nucleic acid sequences and constructs encoding one or more fatty acid desaturase sequences are used to generate transgenic safflower plants that contain and express one or more of these sequences and produce high levels of GLA in safflower seeds. Provided are transgenic safflower plants and seeds that produce high levels of GLA. Additionally provided are oils produced from seeds of this invention. The invention also relates to methods of treating a variety of diseases including nervous system disorders, inflammatory conditions, cancer and cardiovascular disorders using the oils of this invention.
    Type: Application
    Filed: May 22, 2006
    Publication date: March 22, 2007
    Inventors: Vic Knauf, Christine Shewmaker, Frank Flider, Donald Emlay, Eric Rey
  • Publication number: 20070016981
    Abstract: By this invention, compositions and methods of use of plant desaturase enzymes, especially ?-9 desaturases, are provided. Of special interest are methods and compositions of amino acids and nucleic acid sequences related to biologically active plant desaturases as well as sequences, especially nucleic acid sequences, which are to be used as probes, vectors for transformation or cloning intermediates. Biologically active sequences may be found in a sense or anti-sense orientation as to transcriptional regulatory regions found in various constructs.
    Type: Application
    Filed: May 2, 2006
    Publication date: January 18, 2007
    Inventors: Gregory Thompson, Vic Knauf
  • Publication number: 20060037112
    Abstract: A series of independent non-transgenic mutations found in the fruit PG gene of tomato; tomato plants having these mutations in their fruit PG gene; and a method of creating and identifying similar and/or additional mutations in the PG gene by screening pooled and/or individual tomato plants. The tomato plants of the present invention exhibit reduced PG enzyme activity and fruit that soften more slowly post harvest without having the inclusion of foreign nucleic acids in their genomes.
    Type: Application
    Filed: October 7, 2005
    Publication date: February 16, 2006
    Inventors: Claire McCallum, Ann Slade, Trenton Colbert, Vic Knauf, Susan Hurst
  • Publication number: 20050262588
    Abstract: The present invention is directed to nucleic acid molecules and nucleic acid constructs, and other agents associated with fatty acid synthesis, particularly the ratios of saturated and unsaturated fats. Moreover, the present invention is directed to plants incorporating such agents where the plants exhibit altered ratios of saturated and unsaturated fats. In particular, the present invention is directed to plants incorporating such agents where the plants exhibit altered levels of saturated and unsaturated fatty acids.
    Type: Application
    Filed: June 20, 2003
    Publication date: November 24, 2005
    Inventors: Katayoon Dehesh, Vic Knauf
  • Patent number: 5955329
    Abstract: Methods of altering substrate specificity of plant acyl-ACP thioesterases, and engineered plant acyl-ACP thioesterases so produced are provided. The C-terminal two thirds portion of plant thioesterases is identified as desirable for such modifications. DNA sequences and constructs for expression of engineered thioesterases, as well as the novel thioesterases produced therefrom are also provided. Such DNA sequences may be used for expression of the engineered thioesterases in host cells, particularly seed cells of oilseed crop plants, for the modification of fatty acid composition. A C12 preferring plant acyl-ACP thioesterase described herein may be altered to obtain a plant thioesterase having approximately equal activity on C14 and C12 substrates. Further modification of the C12 enzyme yields a thioesterase having greater activity on C14 as compared to C12 substrates.
    Type: Grant
    Filed: May 15, 1995
    Date of Patent: September 21, 1999
    Assignee: Calgene, Inc.
    Inventors: Ling Yuan, Katayoon Dehesh, Jean Kridl, Vic Knauf
  • Patent number: 5759829
    Abstract: Regulation of expression of genes encoded for in plant cell genomes is achieved by integration of a gene under the transcriptional control of a promoter which is functional in the host and in which the transcribed strand of DNA is complementary to the strand of DNA that is transcribed from the endogenous gene(s) one wishes to regulate. The integrated gene, referred to as antisense, provides an RNA sequence capable of binding to naturally existing RNAs, exemplified by polygalacturonase, and inhibiting their expression, where the anti-sense sequence may bind to the coding, non-coding, or both, portions of the RNA. The antisense construction may be introduced into the plant cells in a variety of ways and be integrated into the plant genome for inducible or constitutive transcription of the antisense sequence. A wide variety of plant cell properties may be modified by employing this technique.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: June 2, 1998
    Assignee: Calgene, Inc.
    Inventors: Christine K. Shewmaker, Jean C. Kridl, William R. Hiatt, Vic Knauf
  • Patent number: 5453566
    Abstract: Regulation of expression of genes encoded for in plant cell genomes is achieved by integration of a gene under the transcriptional control of a promoter which is functional in the host and in which the transcribed strand of DNA is complementary to the strand of DNA that is transcribed from the endogenous gene(s) one wishes to regulate. The integrated gene, referred to as antisense, provides an RNA sequence capable of binding to naturally existing RNAs, exemplified by polygalacturonase, and inhibiting their expression, where the anti-sense sequence may bind to the coding, non-coding, or both, portions of the RNA. The antisense construction may be introduced into the plant cells in a variety of ways and be integrated into the plant genome for inducible or constitutive transcription of the antisense sequence. A wide variety of plant cell properties may be modified by employing this technique.
    Type: Grant
    Filed: August 27, 1991
    Date of Patent: September 26, 1995
    Assignee: Calgene, Inc.
    Inventors: Christine K. Shewmaker, Jean C. Kridl, William R. Hiatt, Vic Knauf
  • Patent number: 5107065
    Abstract: Regulation of expression of genes encoded for in plant cell genomes is achieved by integration of a gene under the transcriptional control of a promoter which is functional in the host and in which the transcribed strand of DNA is complementary to the strand of DNA that is transcribed from the endogenous gene(s) one wishes to regulate. The integrated gene, referred to as anti-sense, provides an RNA sequence capable of binding to naturally existing RNAs, exemplified by polygalacturonase, and inhibiting their expression, where the anti-sense sequence may bind to the coding, non-coding, or both, portions of the RNA. The antisense construction may be introduced into the plant cells in a variety of ways and be integrated into the plant genome for inducible or constitutive transcription of the anti-sense sequence. A wide variety of plant cell properties may be modifed by employing this technique.The pCGN978xK12 was deposited at the A.T.C.C. on Mar. 25, 1986, and given Accession No.
    Type: Grant
    Filed: August 30, 1988
    Date of Patent: April 21, 1992
    Assignee: Calgene, Inc.
    Inventors: Christine K. Shewmaker, Jean C. Kridl, William R. Hiatt, Vic Knauf
  • Patent number: 4801540
    Abstract: Polygalacturonase DNA sequence and its use in modulating polygalacturonase expression in plant cells. DNA constructions are provided. The transit peptide finds use with heterologous peptides.
    Type: Grant
    Filed: January 2, 1987
    Date of Patent: January 31, 1989
    Assignee: Calgene, Inc.
    Inventors: William R. Hiatt, Raymond E. Sheehy, Christine K. Shewmaker, Jean C. Kridl, Vic Knauf